Commentary: Expanding Access to Alzheimer’s Treatment

Promising new medicines could soon be available to help patients fend against this disease. Government must ensure Medicare is able to cover them.

Approximately six million Americans are living with some form of Alzheimer’s, a number poised to double over the coming decades. Citizens are living 30 years longer than a century ago, primarily due to incredible advances in the field of medicine. Future opportunities are limitless if we foster an environment that rewards rather than discourages innovation. Unfortunately, that’s not what our leaders in Washington are doing.

Read More

Buddy Carter Commentary: Democrats’ Heads Are in the Clouds When It Comes to Lowering Drug Prices

Republicans have a plan to combat high prescription drug prices, without reverting to socialist price controls.

When I was a practicing pharmacist, I witnessed seniors trying to decide whether to pay for their medicine or pay for their groceries. I witnessed mothers crying because they couldn’t afford their children’s medicine.

Read More

Commentary: Alzheimer’s Research Pipeline Is Poised to Conquer Alzheimer’s with Combination Drug Treatments

The recent approval of Aduhelm, a drug that removes amyloid plaques from the brains of people with Alzheimer’s, is a reason for cautious celebration. Not just because it is the first new treatment approved in 17 years, but because it is the first piece of a complex puzzle that researchers are hot on the trail of solving.

Read More